By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Mary Jane's PostMary Jane's Post
  • Tech
  • Science
  • Culture & Arts
  • Press Releases
  • More
    • About Us
    • Advertise
    • Monthly Give-Away
    • Partner With Us
  • Join UsNew
Reading: Global Drug Of Abuse Testing Services Market Report 2021: Drug Testing is Considered a Violation of Privacy Rights in Some Countries – ResearchAndMarkets.com
Share
0

No products in the cart.

Aa
Mary Jane's PostMary Jane's Post
Aa
  • Press Releases
  • Submit News
  • Join UsNew
Search
  • Topics
    • Business
    • Cannabis Community
    • Cannabis Tech
    • Culture & Arts
    • Industry Leaders
    • Press Releases
  • About Us
    • Guest Columnist
    • Ambassador
    • Partner With Us
Have an existing account? Sign In
Follow US
©2018 - 2022 TheRkive Entertainment Group, LLC. All Rights Reserved.
Mary Jane's Post > Press Releases > Global Drug Of Abuse Testing Services Market Report 2021: Drug Testing is Considered a Violation of Privacy Rights in Some Countries – ResearchAndMarkets.com
Press Releases

Global Drug Of Abuse Testing Services Market Report 2021: Drug Testing is Considered a Violation of Privacy Rights in Some Countries – ResearchAndMarkets.com

Business Wire
Posted Business Wire October 21, 2021
Updated 2021/10/21 at 4:18 PM
4 Min Read
SHARE

DUBLIN–(BUSINESS WIRE)–The “Global Drug Of Abuse Testing Services Market Size, Share & Trends Analysis Report by Drug Type (Cannabis/Marijuana, Opioids, Cocaine, Alcohol, LSD, Amphetamine & Methamphetamine), by Region, and Segment Forecasts, 2021-2028” report has been added to ResearchAndMarkets.com’s offering.

logo Cannabis News

The global drug of abuse testing services market size is expected to reach USD 3.8 billion by 2028 and is expected to expand at a CAGR of 5.2% from 2021 to 2028.

The imposition of stringent laws mandating alcohol and illicit substance abuse testing is anticipated to drive the market during the forecast period. However, the violation of privacy rights while drug testing is considered a challenge and impedes the adoption of such testing services.

Workplace substance abuse is on the rise despite random tests being conducted by organizations. Commonly abused illicit drugs on the job are cannabis and cocaine. In the workplace, substance abuse might lead to significant loss of productivity, physical injuries, and even fatalities.

On the basis of various drug abuse surveys, around 22.5% of people do not admit using alcohol or any illicit drugs during working hours. Around 1 in 10 respondents say that they come prepared to avoid the risk of random tests at the workplace. Therefore, there is a growing need for rapid and frequent drug of abuse testing at the workplace in order to minimize loss of productivity, absenteeism, and healthcare costs.

However, with the COVID-19 crisis and subsequent lockdown scenarios throughout the world, people are staying at and working from home, which is expected to reduce the number of substance abuse cases at the workplace.

The National Institute on Drug Abuse (NIDA) has been established as one of the major federal agencies focused on supporting scientific research on drug use disorders and their consequences, thus improving public health.

In March 2020, the NIDA issued a Notice of Special Interest (NOSI) highlighting the urgent need for research and data collection and analysis on the risks of COVID-19 infection in people suffering from substance use disorders. This pandemic is a potential threat to individuals who smoke tobacco or marijuana or try vaping, as the infection affects the lungs.

This initiative aims at the submission of applications for Competitive Revisions to active grants, targeting research about SARS-CoV-2 infection risks in individuals with substance use disorders, especially with marijuana, nicotine, methamphetamine, and opioids.

Drug Of Abuse Testing Services Market Report Highlights

  • By drug type, cannabis/marijuana accounted for the largest market share in 2020. This can be attributed to the growing usage of cannabis across the world, especially in the U.S.
  • The opioids drug type segment held a significant revenue share in 2020 due to the growing cultivation and trading of opioids in Asian countries and a rise in related overdose deaths
  • North America accounted for the largest market share in 2020 due to the highest consumption of illicit drugs in the U.S. as well as the imposition of various drug policies mandating drug screening in the country
  • Latin America is anticipated to witness the fastest growth during the forecast period owing to the increasing usage and trading of illegal drugs
  • COVID-19 has led to a significant rise in alcohol and other substance abuse globally; however, demand for drug testing has declined due to the increased focus on measures to combat the pandemic

Market Dynamics

Market driver analysis

  • High prevalence of substance abuse & growing demand for its treatment
  • Increase in government initiatives to monitor substance abuse
  • Stringent law mandating alcohol and drug testing

Market Restraint Analysis

  • Drug testing is considered a violation of privacy rights in some countries
  • Lack of awareness about sepsis

Market Opportunity Analysis

  • Focus on development of innovative testing services

Drug of Abuse Testing Services Market Analysis Tools

  • Industry analysis – Porter’s
  • PESTEL Analysis

Company Profiles

  • Quest Diagnostics, Inc.
  • Abbott Laboratories
  • Clinical Reference Laboratory, Inc.
  • Laboratory Corporation of America Holdings
  • Cordant Health Solutions
  • Legacy Medical Services, LLC.
  • DrugScan
  • Omega Laboratories, Inc.
  • Psychemedics Corporation
  • Millennium Health
  • Mayo Clinic Laboratories
  • Precision Diagnostics
  • American Substance Abuse Professionals, Inc.
  • United States Drug Testing Laboratories, Inc. (USDTL)
  • LGC Group

For more information about this report visit https://www.researchandmarkets.com/r/r9oyo1

Cannabis News

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

You Might Also Like

Heritage Cannabis Reports 2021 Year-End Financial Results

Flora Growth Launches Vessel in Canada; Signs Deal With Ontario Cannabis Store and Launches Vesselbrand.ca

Houston Area Army Veteran Reclaims Life, Eliminates Opioid Use with Medical Cannabis

Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2022 Financial Results and Recent Updates

Heritage Cannabis Announces Corporate Update and Highlights Significant Sales Growth, Market Share and Growing Distribution

TAGGED: Business Wire
Business Wire October 21, 2021
Share this Article
Facebook Twitter Pinterest LinkedIn Reddit
Share
Business Wire
Posted by Business Wire
Follow:
Business Wire, a Berkshire Hathaway company, is the global leader in press release distribution and regulatory disclosure. Investor relations, public relations, public policy, and marketing professionals rely on Business Wire for secure and accurate distribution of market-moving news and multimedia.
Previous Article Eaze Launches On-Demand Cannabis Delivery in Ann Arbor and Grand Rapids, MI With Detroit Delivery Launching In Coming Weeks
Next Article Global Hydroponics (Aggregate Systems, Liquid Systems) Market Analysis & Forecast Report 2021-2028 – ResearchAndMarkets.com
- Advertisement -
Ad imageAd image

Stay Connected

Facebook Like
Twitter Follow
Pinterest Pin
Instagram Follow

You Might Also Like

Heritage Cannabis Reports 2021 Year-End Financial Results

May 12, 2022

Flora Growth Launches Vessel in Canada; Signs Deal With Ontario Cannabis Store and Launches Vesselbrand.ca

May 11, 2022

Houston Area Army Veteran Reclaims Life, Eliminates Opioid Use with Medical Cannabis

May 11, 2022

Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2022 Financial Results and Recent Updates

May 11, 2022
Mary Jane's PostMary Jane's Post

©2018 - 2022 TheRkive Entertainment Group, LLC. All Rights Reserved.

  • PRIVACY
  • TERMS OF USE
  • CONTRIBUTOR AGREEMENT
  • CONTRIBUTOR GUIDELINES

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Register Lost your password?